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Recent studies suggest that delirium is associated with risk of dementia and also acceleration of decline in existing dementia.
However, previous studies may have been confounded by incomplete ascertainment of cognitive status at baseline. Herein, we
used a true population sample to determine if delirium is a risk factor for incident dementia and cognitive decline. We also examined
the effect of delirium at the pathological level by determining associations between dementia and neuropathological markers of
dementia in patients with and without a history of delirium. The Vantaa 85+ study examined 553 individuals (92% of those eligible)
aged585 years at baseline, 3, 5, 8 and 10 years. Brain autopsy was performed in 52%. Fixed and random-effects regression models
were used to assess associations between (i) delirium and incident dementia and (ii) decline inMini-Mental State Examination scores
in the whole group. The relationship between dementia and common neuropathological markers (Alzheimer-type, infarcts and
Lewy-body) was modelled, stratified by history of delirium. Delirium increased the risk of incident dementia (odds ratio 8.7, 95%
confidence interval 2.1–35). Deliriumwas also associatedwith worsening dementia severity (odds ratio 3.1, 95% confidence interval
1.5–6.3) as well as deterioration in global function score (odds ratio 2.8, 95% confidence interval 1.4–5.5). In the whole study
population, delirium was associated with loss of 1.0 more Mini-Mental State Examination points per year (95% confidence interval
0.11–1.89) than those with no history of delirium. In individuals with dementia and no history of delirium (n = 232), all pathologies
were significantly associated with dementia. However, in individuals with delirium and dementia (n = 58), no relationship between
dementia and these markers was found. For example, higher Braak stage was associated with dementia when no history of delirium
(odds ratio 2.0, 95% confidence interval 1.1–3.5, P = 0.02), but in those with a history of delirium, there was no significant rela-
tionship (odds ratio 1.2, 95% confidence interval 0.2–6.7, P = 0.85). This trend for odds ratios to be closer to unity in the delirium and
dementia groupwas observed for neuritic amyloid, apolipoprotein " status, presence of infarcts, a-synucleinopathy and neuronal loss
in substantia nigra. These findings are the first to demonstrate in a true population study that delirium is a strong risk factor for
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incident dementia and cognitive decline in the oldest-old. However, in this study, the relationship did not appear to be mediated
by classical neuropathologies associated with dementia.
Keywords: delirium; dementia; neuropathology; population-based; epidemiology
Abbreviation: MMSE = Mini-Mental State Examination
Introduction
Delirium is a severe, acute neuropsychiatric syndrome that affects
at least 15% of hospitalized older adults (Inouye, 2006; Siddiqi
et al., 2006; Young and Inouye, 2007; MacLullich and Hall, 2011).
There has been much interest in whether delirium may be a
marker for future dementia risk. In a population of memory
clinic patients already diagnosed with dementia, delirium was
associated with faster decline in cognitive test scores (Fong
et al., 2009). Delirium was associated with future dementia in a
follow-up study of hospital patients aged 565 years [odds ratio
(OR) 6.0, 95% confidence interval (CI) 1.8–20] (Rockwood et al.,
1999). Higher rates of dementia diagnosis were also observed in
subjects with postoperative delirium following elective hip surgery
(relative risk 1.9, 95% CI 1.1–3.3) (Kat et al., 2008). These results
are consistent with a systematic review of dementia outcomes
following hospitalization with delirium (Witlox et al., 2010).
However, because dementia itself is a major risk factor for delir-
ium, and around half of dementia is undiagnosed (Sampson et al.,
2009), the key question of whether delirium is a risk factor for
new onset dementia remains unanswered (MacLullich et al.,
2009). Moreover, studies of selected hospital and memory clinic
samples may be biased toward more severe disease. Capturing the
full range of dementia risk following delirium within a
population-based design would provide more generalizable risk
estimates.
The Vantaa 85 + study is a true population-based cohort study of
553 individuals (92% of those eligible) aged585 years at baseline,
3, 5, 8 and 10 years (Polvikoski et al., 2001, 2006). Vantaa 85 + is
one of only six population-based cohorts with neuropathology
information (Zaccai et al., 2006), and is the only one to have ascer-
tained delirium. In addition, using autopsy data, the burden of
standard dementia-related neuropathology markers in individuals
with and without a history of delirium were examined.
The present study addressed two main questions. First, does
delirium increase the risk of incident dementia? Second, in those
with dementia, is a history of delirium associated with an increased
burden of standard neuropathology markers of dementia? We also
determined if delirium was associated with accelerated cognitive
decline and increased severity of dementia.
Materials and methods
Sample characteristics
The Vantaa 85 + cohort study methods have previously been reported
in detail (Polvikoski et al., 2006). Briefly, the study population
comprised 553 individuals, representing 92% of the 601 adults aged
585 years living in Vantaa, Finland in 1991. Participants were re-
cruited from the whole population, unrestricted by residential or
health status. Follow-up for incident dementia and other markers of
health status occurred at 3 (n = 277), 5 (n = 155), 8 (n = 65) and 10
(n = 25) years. The study received approval from the Ethics Committee
of the City of Vantaa.
Clinical assessments
Dementia diagnosis by DSM-III-R (Diagnostic and Statistical Manual
of Mental Disorders, third edition, revised) criteria (APA, 1987)
was agreed by two neurologists simultaneously examining each par-
ticipant. Dementia subtypes were classified using National
Institute of Neurological and Communicative Disorders and Stroke
and the Alzheimer’s Disease and Related Disorders Association
for Alzheimer’s dementia (McKhann et al., 1984) and National
Institute of Neurological Disorders and Stroke and Association
Internationale pour la Recherche´ et l’Enseignement en Neurosciences
for vascular dementia (Roman et al., 1993). Cognition was assessed at
every wave using the Mini-Mental State Examination (MMSE)
(Folstein et al., 1975), the Short Portable Mental Status
Questionnaire (Pfeiffer, 1975), and the Clinical Dementia
Rating Scale (Morris, 1993). Depression was assessed using the
Depression Status Inventory (Zung, 1972). Functional abilities
were measured with the Personal and Instrumental Activities of Daily
Living scales (Katz et al., 1963; Lawton and Brody, 1969). Hospital,
primary care and social work records were also used to help
identify incident dementia in participants between last assessment
and death.
At each interview, the examining neurologists assessed participants
and informant(s) for a history of any episodes of delirium, specific-
ally assessing: changes in cognitive functioning, level of alertness,
psychotic and perceptual symptoms, with reference to a checklist of
DSM-III-R criteria for delirium diagnosis (Rahkonen et al., 2001).
The reported history and number of episodes of delirium were corro-
borated with hospital case notes that were available at the time
of assessment, and any additional likely episodes of delirium not
recalled by participants or informants were ascertained through
detailed inspection of hospital and primary care case notes.
Therefore, the study ascertainment of delirium was retrospectively
derived from multiple sources and the overall diagnosis accepted if
the examining neurologists judged there was sufficient evidence
from participant and informant recall and/or indication in the medical
notes.
At baseline and at each subsequent wave, the presence of the
following conditions was assessed through interview and medical re-
cords: myocardial infarction; congestive heart failure; peripheral vascu-
lar disease, cerebrovascular disease; chronic lung disease; connective
tissue disease; hemiplegia; diabetes mellitus, diabetes with complica-
tions; tumours; leukaemia; and lymphoma.
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Mortality
Dates of death were collected through Statistics Finland.
Neuropathology
Brains were fixed in phosphate-buffered 4% formaldehyde solution for
at least 2 weeks. All specimens were macroscopically examined by one
pathologist (Tuomo Polvikoski), blind to all clinical data, using a stan-
dardized dissection and sampling protocol. Cerebral infarcts and
lacunes visible to the naked eye were identified by examination of
the surface of the brain and from 1-cm thick coronal slices of the
cerebral hemispheres, from 5-mm thick transverse slices of the brain-
stem and sagittal slices of the cerebellum. These lesions were subse-
quently histologically verified to be infarcts. In addition, a standardized
set of samples were obtained from the middle frontal, superior tem-
poral and middle temporal gyri, inferior parietal lobule, uncal region,
hippocampal body, cingulate gyrus, occipital lobe (including the pri-
mary visual cortex) and midbrain. The protocols for quantifying
Alzheimer-type [Braak stage (0 to 6); neuritic amyloid plaque (none
0 to severe 3)] (Polvikoski et al., 1995, 2006), infarcts (present or
absent) (Rastas et al., 2007; Ahtiluoto et al., 2010) and Lewy body
[neuronal loss in substantia nigra (none 0 to severe 3);
-synucleinopathy (none 0 to severe 3) (Oinas et al., 2009)] patholo-
gies have been described in detail previously (Supplementary material).
Genetic testing
Apolipoprotein E (ApoE) genotyping was performed using both PCR
and solid-phase mini-sequencing techniques (Syvanen et al., 1993;
Polvikoski et al., 2006).
Statistical analyses
STATA 11.1 (StataCorp) was used for all analyses. Logistic regression
was used to determine if episodes of delirium were associated with
new onset of dementia. Because dementia neuropathology tends to be
mixed in unselected populations (Matthews et al., 2009), we did not
attempt to assess the associations of delirium with clinical dementia
subtypes. Only episodes of delirium occurring at least one wave prior
to participants last known as having no dementia were regarded as an
exposure; controls were subjects in whom dementia was never ascer-
tained using the thorough methods described above. Logistic regres-
sion was also used to assess worsening in Clinical Dementia Rating
score in relation to a history of delirium prior to that wave. Similar
analyses were conducted for functional sequelae, where outcomes in
logistic models represented worsening in global function score. The
association between delirium history at baseline and mortality was
determined using a Cox proportional hazards model. All models
were adjusted for age, sex and co-morbidities (using equivalent
weightings from the Charlson co-morbidity index) (Charlson et al.,
1987). CIs of 95% were employed, and are reported in the results.
Post-model testing included examination of Pearson residuals for lo-
gistic models and Schoenfeld residuals, and log–log survival plots for
proportional hazards models.
Longitudinal change in MMSE was modelled using random-effects
linear regression for both MMSE at study entry (intercept) and rate of
change in MMSE (slope), having first compared model fit for fixed
intercepts and slopes using maximum likelihood estimates. ‘Time in
study’ was used as the time metric. Covariance matrices were unstruc-
tured. The effect of delirium history at baseline, mean-centred age at
baseline, sex, baseline functional status on intercept and slope was
considered, and model fit assessed using likelihood ratio tests. The
final model included adjustment for these variables for MMSE at
study entry with an additional term adjusting for the influence of de-
lirium history at baseline on rate of MMSE change. Finally, a quadratic
term for the time metric was tested. After fitting models, assumptions
were checked by constructing Q–Q plots of the standardized residuals.
In keeping with previous methods, neuropathological variables
were dichotomized into ‘high’ or ‘low’ values (Savva et al., 2009;
Brayne et al., 2010). This approach allows for simpler interpretation
and is more likely to be robust. The relationships between these
markers (exposure) and dementia (outcome) were evaluated using
logistic regression models, adjusted for sex and age at death (Savva
et al., 2009). These associations were then assessed, stratified by
delirium history, to determine if the OR for the dementia–pathology
association differed between those with and without a history
of delirium. The possibility of a statistical interaction was also
tested using a multiplicative interaction term (delirium  pathology)
(Supplementary material).
Results
Participant characteristics
Participant characteristics are summarized in Table 1. Figure 1
shows the flow diagram for the study. At baseline, there were
71 subjects (13%) with a history of delirium. There were no dif-
ferences in age, sex or years of education between those with and
without a history of delirium. However, subjects with a history of
delirium were more likely to have prevalent dementia (77% versus
Table 1 Clinical characteristics of participants at baseline
No history
of delirium
5 1 episode
of delirium
P-value
n at baseline (%) 482 (87) 71 (13)
Person years 1901 164
Mean age (SD) 88 (2.9) 90 (3.1) 1.00
Sex (% females) 385 (80) 55 (77) 0.64
Proportion with 44 years
education (%)a
98 (23) 10 (17) 0.31
Mean time in study
(years, IQR)
3.2 (1.6–5.9) 1.9 (0.9–3.2) 50.01
Co-morbidity score at
baseline (IQR)b
3 (1–4) 3 (2–5) 50.01
Functionally independent
at baseline (%)
321 (67) 24 (34) 50.01
Prevalent dementia 159 (33) 55 (77) 50.01
MMSE
Baseline (IQR) 21 (17–26) 15 (10–19) 50.01
Last follow-up (IQR) 19 (11–24) 13 (9–17) 50.01
A total of 121 participants experienced delirium at any time during the study
(22%). Of these, 58 were brain donors (48%) and 232 brain donors had no
history of delirium (54%) (P = 0.26).
a Co-morbidity index uses the same weightings as the Charlson index.
The maximum score is 19.
‘Functionally independent’ refers to those who reported being fully independent
or needing minor assistance to complete activities of daily living.
b Years of education undetermined in 71 participants.
IQR = interquartile range.
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33%, P50.01) and lower MMSE scores (15/30 versus 21/30,
P5 0.01). A delirium episode was recorded at least once during
the study in 121 subjects (22%). Brain autopsy data were available
in similar proportions of individuals with and without an episode of
delirium (54% and 48%, respectively, P = 0.26).
Delirium and dichotomous outcomes
A history of delirium at any wave in subjects with no dementia was
associated with a significantly higher risk of new dementia at the
following wave (OR 8.7, 95% CI 2.1–35) (Table 2). For all partici-
pants, delirium was also associated with a worse Clinical Dementia
Rating score at follow-up (OR 3.1, 95% CI 1.5–6.3) as well as
deterioration in global function scores (OR 2.8, 95% CI 1.4–5.5)
(Table 2). A history of delirium at study entry was associated with
increased mortality, even after adjustment for co-morbidities [hazard
ratio 1.6, 95% CI 1.2–2.1] (full models in Supplementary Table 1)
Delirium and decline in Mini-Mental
State Examination score
MMSE trajectory was best described by a quadratic model when
contrasted with a linear model (Supplementary Fig. 1). Figure 2
shows the predicted trajectories from the model fitted (Supple-
mentary Table 2). MMSE scores at baseline were estimated at
28.6 (95% CI 26.5–30.8), representing cognitive function for an
individual with zero value on all covariates. In the whole popula-
tion, cognitive function declined at 0.75 points per year (95% CI
0.49–1.0), with a change in annual rate of decline of 0.07 points
(95% CI 0.4–0.1). Baseline MMSE scores of individuals with his-
tory of delirium were 3.0 points (95% CI 1.4–4.5) lower than
MMSE scores of individuals without any delirium. A history of
delirium was associated with a significantly faster rate of decline
in MMSE scores with decline of 1.0 (95% CI 0.11–1.89) MMSE
point per year compared to those without delirium.
Delirium, dementia and
neuropathological markers of dementia
All neuropathological markers were significantly associated with
dementia. However, when stratifying the group by history of de-
lirium, the relationship between dementia and all markers became
stronger in individuals with no history of delirium (all ORs consist-
ently larger) (Fig. 3 and Supplementary Table 3). Conversely, in
the group with delirium there were no significant associations be-
tween dementia and neuropathology and genotype markers (all
ORs closer to unity). For example, higher Braak stage was asso-
ciated with dementia but no delirium (OR 2.0, 95% CI 1.1–3.5,
P = 0.02), but in those with a history of delirium, there was no
significant relationship (OR 1.2, 95% CI 0.2–6.7, P = 0.85). This
pattern was observed consistently with neuritic amyloid, ApoE
Eligible
601
Recruited htaeDaitnemeDaitnemed oNDeath
214Wave A 553 
127 
7057 631B evaW 144146
Wave C 481838 7990
21
66
+      54+3194Wave D 174     + 22328
34Total end Wave D 223 26828
Incident dementia
Death
339
Figure 1 Flow diagram of follow-up in the Vantaa study. Illustration enumerating dementia and mortality events in Vantaa over time.
Wave A = 1991; Wave B = 1994; Wave C = 1996 and Wave D = 1999.
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status, presence of infarcts, -synucleinopathy and neuronal loss in
substantia nigra. While this raises the possibility that the relation-
ship between dementia and neuropathological markers is modified
by a history of delirium, the sample size was under-powered to
conclude this statistically using an interaction term (Supplementary
Table 4). Delirium history was not itself associated with any of the
neuropathological markers of dementia or ApoE status among the
brain donors (Supplementary Table 5).
Discussion
This is the first study to examine the hypothesis that delirium is a
risk factor for dementia using a true population-based sample of
older individuals. The results definitively confirm this hypothesis.
Additionally, in individuals with existing dementia, delirium was
associated with worsening dementia severity, worsening global
functional status and higher mortality. Moreover, in the whole
population, a history of delirium was significantly associated with
an accelerated decline in MMSE scores. This is also the first pro-
spective cohort study to examine the potential effects of delirium
history on the relationships between dementia and its neuropatho-
logical markers. Individuals with dementia and no history of delir-
ium had strong associations with Alzheimer-type, infarcts and
Lewy body pathology. In contrast, those with dementia and a
history of delirium showed no such relationships. Though this is
an intriguing finding, the study was not powered to determine if
delirium is genuinely associated with an altered pattern of
pathology.
The present results are consistent with studies reporting cogni-
tive decline after delirium or inter-current illness where there have
been pre-morbid assessments of cognition. As mentioned above,
follow-up of memory-clinic patients showed delirium was subse-
quently associated with greater decline in cognitive test scores
30 β P valueIntercept 28.64 <0.01
Delirium -2.95 <0.01
Age
-
25
0.15
Sex -1.21 0.04
Functional status -2.86 <0.01
Slope -0.75 <0.01
Delirium effect on rate -1.00 0.03
Slope acceleration 0 07 <0 01
20
-
0
15
M
M
SE
No delirium
5
1
Delirium
0
0 2 4 6 8 10
Years in study
.
0.08
Figure 2 Longitudinal trajectory of change in MMSE score over time. Predicted trajectory of MMSE change for those with or without a
history of delirium at baseline. Co-efficients and P-values are shown. The estimates for the intercept and slope are given when all
covariates = 0. The estimate changes with the addition of each covariate, subtracting the appropriate b co-efficient where: delirium = yes;
age per year; sex = female; functional status per increase in five-point scale. The full model, along with 95% CIs for each estimate, and
related graphs are given in the Supplementary material.
Table 2 The association of between delirium and
clinical outcomes
Outcome Delirium
(n)
No delirium
(n)
LCI UCI P-value
Dementiaa 10 311 OR 8.65 2.13 35.12 50.01
Dementia
worseningb
38 226 OR 3.06 1.49 6.29 50.01
Functional
worseningb
42 230 OR 2.76 1.38 5.52 50.01
Mortalityc 71 469 HR 1.61 1.25 2.10 50.01
The results of four separate models where delirium is the exposure of interest,
adjusted by age, sex and co-morbidity, given with 95% CIs [lower confidence
interval (LCI), upper confidence interval (UCI)].
a The dementia outcome gives the OR that a person with a history of delirium but
no dementia was then diagnosed with incident dementia at the following wave.
b The OR of worsening in dementia (at least one point decline in clinical dementia
rating scale) or function (at least one category decline in five-point scale from
independent to fully dependent for all care needs) between baseline and first
follow-up in individuals also experiencing delirium.
c Association between co-morbidity and mortality is also significant in this model
(HR 1.24, 95% CI 1.18–1.30) per point on co-morbidity index.
All Pearson and Schoenfeld residuals P4 0.1.
The full models are given in the Supplementary material.
HR = hazard ratio.
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(Fong et al., 2009). In addition, a report from the Adult Changes
in Thought study found that critical illness (without specifically
considering delirium) was associated with incident dementia
(hazard ratio 1.4, 95% CI 1.1–1.7) (Ehlenbach et al., 2010).
Participants in the Health and Retirement Study who had an
inter-current episode of severe sepsis also had a higher risk of
being subsequently diagnosed with severe cognitive impairment
(OR 3.4, 95% CI 1.5–7.3) (Iwashyna et al., 2010). The larger
effect size in the present study may reflect the older age in this
cohort.
The results are also consistent with the emerging evidence from
animal models of delirium demonstrating that in vulnerable ani-
mals, systemic inflammatory insults can cause transient, reversible
deterioration in cognition and significant acceleration in disease
progression after the transient impairments have resolved
(Cunningham, 2011). A single, moderate dose of lipopolysacchar-
ide (as a bacterial mimic) or polyinosinic:polycytidylic acid (as a
viral mimic), consistent with the level of inflammatory insult that
typically induces delirium in vulnerable humans, has been shown
to induce de novo neuronal death in animals with existing neuro-
degenerative disease (Cunningham et al., 2005; Field et al., 2010),
and to accelerate the progression of disease without obvious ef-
fects on extracellular amyloidosis (Cunningham et al., 2009). In
this context, it is of note that a case-control autopsy study of
individuals who died with delirium showed differential increases
in IL6 and CD68-positive microglia (Munster et al., 2011).
Consistent with these findings, the present study suggests the
possibility that dementia following delirium may not be as strongly
linked with classical dementia neuropathological markers as de-
mentia in those without a history of delirium, but further work
is needed.
This study has several strengths. This cohort has high general-
izability for the oldest-old, and has a high rate of brain autopsy
(Zaccai et al., 2006). The characteristics of the brain donors show
no evidence of systematic bias (Brayne et al., 2010). While it has
been shown that neuropathological assessments can reliably be
made by a single rater (Mirra et al., 1994), it is an advantage
that all scoring was interpreted by the same neuropathologist.
There were multiple waves of measurement over a decade; this
allows accurate assessment of longitudinal change.
Some limitations of the present study should be acknowledged.
Only changes from age 585 years could be studied and this
resulted in substantial losses to follow-up due to mortality. There
is likely to be a survivor effect and this may result in selective
differences in clinical and genetic characteristics. Depression also
has a complex relationship with cognitive assessment and demen-
tia, and no attempt was made to address this in the present ana-
lysis. The results of the random-effects models produced estimated
20 All
8
Never delirium
Ever delirium
2
4
1
O
dd
s r
at
io
0.
5
Braak Amyloid ApoEInfarcts SN loss a-Syn
Pathology
Figure 3 Relationship between delirium, dementia and neuropathology/genotype. Display of logistic regression models, with 95% CIs.
The y-axis is log-scaled. Models show association between dementia and pathology (or genotype), adjusted by age at death and sex.
Markers were treated as dichotomous variables (high/low). For each marker, the relationship is given for the whole population, and
then stratified by delirium history (n = 58 with history of delirium; n = 232 no history of delirium). SN = substantia nigra;
Syn = synucleinopathy.
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parameters comparable to other population-based studies of gen-
eral cognitive decline (Terrera et al., 2008). However, similar to
many prospective studies of ageing, attrition was significant and
data missing-not-at-random was not accounted for. Though aut-
opsy rates were high in our study, the absolute number of cases in
each category of delirium exposure was relatively low.
Self-reported (or informant-reported) delirium may be subject to
recall bias, though this is mitigated by corroborating the history
with medical records during the interview. Though the history of
delirium was specifically assessed at each wave, this approach is
not as accurate as clinician assessment during delirium and is likely
to under-detect delirium given that diagnosis rates in routine clin-
ical practice are generally considerably below the true prevalence
(Flaherty et al., 2007). In the absence of robust delirium ascertain-
ment being embedded in routine hospital care, only a prospective
study in which researchers could assess every patient for delirium
during every hospital admission could overcome this issue. This is
impractical, however, and combining patient and informant inter-
views with inspection of case notes is a pragmatic alternative.
Indeed, medical records have been validated for the diagnosis of
delirium history (Inouye et al., 2005), and the diagnostic accuracy
for past episodes is likely to be higher if case notes are reviewed in
conjunction with clinical interview as is the case in the present
study.
This study confirmed that delirium is associated with general
cognitive decline, with an 8-fold increase in incident dementia
and accelerated decline in MMSE scores. Previous investigations
for other dementia risk factors (Daviglus et al., 2011) have often
been dwarfed by the relationship of dementia with older age itself.
The strong association with delirium, even after adjusting for age,
in a general population underscores the clinical importance of de-
lirium in relation to dementia risk. Future research should seek to
include prospective delirium measures in cohort studies of demen-
tia, correlating these with neuroimaging and neuropathology find-
ings. Up to 30% of delirium is preventable (Inouye et al., 1999)
and definitive data would come from intervention trials where the
outcome is secondary prevention of dementia. The present study
suggests that this would be a plausible approach.
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